Company Overview and News

 
SAIC VW starts work on $2.5 billion China plant in Audi pivot

22h theedgemarkets
BEIJING (Oct 19): Volkswagen AG’s China venture with SAIC Motor Corp Ltd has started building a $2.5 billion new energy vehicle (NEV) plant in Shanghai, which will make VW’s luxury Audi AG brand cars, a possible first for the venture.
VLKAF

 
SAIC VW starts work on $2.5 billion China plant in Audi pivot

23h reuters
BEIJING (Reuters) - Volkswagen AG’s (VOWG_p.DE) China venture with SAIC Motor Corp Ltd (600104.SS) has started building a $2.5 billion new energy vehicle (NEV) plant in Shanghai, which will make VW’s luxury Audi AG (NSUG.DE) brand cars, a possible first for the venture.
VLKAF

 
SAIC VW starts work on US$2.5 billion China plant in Audi pivot

23h channelnewsasia
Volkswagen AG's China venture with SAIC Motor Corp Ltd has started building a US$2.5 billion new energy vehicle (NEV) plant in Shanghai, which will make VW's luxury Audi AG brand cars, a possible first for the venture.
VLKAF

 
Kia Makes History In Sweden: Becomes Second-Largest Auto Brand In September

2018-10-18 seekingalpha
Major changes are underway in many European car markets, and perhaps none more radical than Sweden during Q3 2018.
VLKAF

14
Tesla secures land in Shanghai for first factory outside US

2018-10-17 nzherald.co.nz
Electric auto brand Tesla Inc. said it signed an agreement Thursday to secure land in Shanghai for its first factory outside the United States, pushing ahead with development despite mounting US-Chinese trade tensions.
VLKAF PCRFY GM

 
U.S. environmental agency says in talks with Volvo over emissions issue

2018-10-17 reuters
STOCKHOLM (Reuters) - The U.S. Environmental Protection Agency said on Wednesday it has been in talks with Volvo over the last few weeks about an issue with catalytic converters causing some of its vehicles to exceed nitrogen oxide emission limits.
VLKAF

14
Tesla secures land in Shanghai for first factory outside U.S.

2018-10-17 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
VLKAF PCRFY GM

 
Audi to pay € 800 m fine in Germany over diesel engine cheating

2018-10-16 thehindubusinessline
Volkswagen said on Tuesday its subsidiary Audi would not contest an € 800-million fine issued by German prosecutors over “deviations from regulatory requirements” in diesel engines.
VLKAF

 
Porsche CFO sees potential IPO reap Ferrari-like multiples

2018-10-15 thestar.com.my
The Porsche 918 Spyder is seen on the second press day of the Paris auto show in Paris, October 3, 2018. - REUTERS
VLKAF

 
Porsche IPO could value carmaker as high as $81 billion, CFO says

2018-10-15 livemint
Porsche AG’s chief financial officer said a share sale of Volkswagen AG’s most profitable unit could unlock value to echo Ferrari NV’s successful public offering and help the sports-car maker raise money if needed.
VLKAF DDAIF

15
The world’s largest car market faces a historic drop

2018-10-12 thestar - 1
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
VLKAF GM DDAIF

14
China auto sales post biggest drop in 7 years as growth engine stalls

2018-10-12 channelnewsasia
China's car sales fell the most in nearly seven years in September, stoking concerns the world's biggest auto market could contract for the first time in decades this year amid cooling economic growth and a biting trade war.
HYUO TM TYT KIMTY TOYOF HYUD VLKAF KIMTF 7203 HYUP GM

14
China auto sales post biggest drop in 7 years as growth engine stalls

2018-10-12 reuters
BEIJING (Reuters) - China’s car sales fell the most in nearly seven years in September, stoking concerns the world’s biggest auto market could contract for the first time in decades this year amid cooling economic growth and a biting trade war.
HYUO TM TYT KIMTY TOYOF HYUD VLKAF KIMTF 7203 HYUP GM

 
European diesel car sales plummet -IEA

2018-10-12 reuters
LONDON, Oct 12 (Reuters) - Diesel car sales in Europe fell sharply in the first half of the year amid buyer concerns over pollution and falling resale value as governments seek to reduce combustion engine car sales.
VLKAF

14
China vehicle sales post biggest drop in nearly 7 years as slowdown bites

2018-10-12 theedgemarkets
BEIJING (Oct 12): China’s vehicle sales slid 11.6 percent in September in their worst monthly drop in nearly seven years, as slowing economic growth and a deepening Sino-U.S. trade war took their toll on the world’s largest auto market.
HYUO TM TYT KIMTY TOYOF HYUD VLKAF KIMTF 7203 HYUP GM

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...